A large 20-year-old registry studying this congenital heart anomaly is starting to yield insights, and complementary prospective and retrospective Cleveland Clinic studies of adults with AAOCA promise to be useful adjuncts.
A large retrospective study suggests that factoring myectomy and atrial fibrillation into risk scores for sudden cardiac death significantly reclassifies risk in patients with hypertrophic cardiomyopathy.
NIH-sponsored project aims to establish normal ECG reference values as a step toward preventing sudden death in the young. Cleveland Clinic Children’s Pediatric Cardiology Chair leads the charge.
With sudden cardiac death an increasing risk as kidney disease progresses, CKD patients would seem to gain from implantable defibrillators. But a Cleveland Clinic analysis shows that the device’s mortality reductions don’t extend to patients in end-stage CKD.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Dr. Saarel is a pediatric electrophysiologist who returns to Cleveland Clinic after a decade at the University of Utah. She fields questions about her research passions, essential trends in pediatric cardiology and more.
For serious athletes, not all changes on cardiac imaging require detraining or quitting the sport. Here’s a glimpse into an expert sports cardiologist’s thinking on when and when not to worry about abnormal findings.
The low risk of sudden cardiac death in young athletes doesn’t merit screening beyond the history and physical exam for most youths. Better training and team-based care at schools promise more benefit than universal ECGs.
With its high degree of sensitivity and high negative predictive value for excluding coronary heart disease, CTA can be a useful test for risk stratification in select patients.